ArticlePharmaceutical research2026

Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy.

Aaditi Karnik et al.PubMed ↗Publisher ↗

No numbers read from the abstract.